Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 18 Aug 2023 for Foghorn Therapeutics Inc., €2.4M.
Filing timeline
BuySaleSamuel Agresta
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
Samuel Agresta: trading record in brief
This profile gathers the share dealings of Samuel Agresta in Foghorn Therapeutics Inc. Altogether 2 filings, all relating to 16 August 2023.
Sales make up the whole of the open-market record (1 sale, €2.4M). Besides market trades, the filings include 1 option exercise.
Most recently, on 18 August 2023, the filings show an open-market sale worth €2.4M in Foghorn Therapeutics Inc. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Samuel Agresta
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
- 311,297 shares@ US$8.2568.9% of flowCommon StockSEC:0001562180-23-006433:1
- 311,297 shares@ US$3.72100.0% of flowCommon StockSEC:0001562180-23-006433:0
2 of 2 declarations